Improvement in pain severity category in clinical trials of pregabalin

Improvement in pain severity category in clinical trials of pregabalin

Bruce Parsons,1 Charles E Argoff,2 Andrew Clair,1 Birol Emir1 1Pfizer, New York, NY, USA; 2Albany Medical Center, Albany, NY, USA Background: Pregabalin is approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM), diabetic peripheral neuropathy (DPN), postherpe...

Full description

Bibliographic Details
Main Authors: Parsons B, Argoff CE, Clair A, Emir B
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Journal of Pain Research
Subjects:
Pregabalin
pain
fibromyalgia
diabetic peripheral neuropathy
postherpetic neuralgia
neuropathic pain
pooled analysis.
Online Access:https://www.dovepress.com/improvement-in-pain-severity-category-in-clinical-trials-of-pregabalin-peer-reviewed-article-JPR

Internet

https://www.dovepress.com/improvement-in-pain-severity-category-in-clinical-trials-of-pregabalin-peer-reviewed-article-JPR

Similar Items